LENZ Therapeutics, Inc. (LENZ)
5.80
+0.57
(+10.90%)
USD |
NASDAQ |
Sep 02, 16:00
5.77
-0.03
(-0.52%)
Pre-Market: 08:13
LENZ Therapeutics Research and Development Expense (Annual) : 18.67M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 18.67M |
| December 31, 2024 | 29.80M |
| December 31, 2023 | 59.50M |
| December 31, 2022 | 64.44M |
| Date | Value |
|---|---|
| December 31, 2021 | 37.93M |
| December 31, 2020 | 9.123M |
| December 31, 2019 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Ocular Therapeutix, Inc. | 197.10M |
| Enveric Biosciences, Inc. | 2.781M |
| Liquidia Corp. | 38.45M |
| Aquestive Therapeutics, Inc. | 17.19M |
| Impact BioMedical, Inc. | 0.34M |